Tersera Therapeutics

ZOLADEX

Manufacturer:

Tersera Therapeutics

Zoladex HCPCS:

J9202

HCPCS Code Descriptor:

Goserelin acetate implant, per 3.6 mg

Category:

J Code

Zoladex NDCs:

70720-0951-30, 70720-0950-36

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Subcutaneous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Zoladex:

ZOLADEX is an Oncology drug manufactured by Tersera Therapeutics and administered via the Subcutaneous route of administration. The J Code: J9202 is aligned to the drug ZOLADEX.

ACCESS PRICING AND MORE BY REGISTERING

J9202 Added Date:

January 1, 1991

J9202 Effective Date:

January 1, 1997

J9202 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Zoladex billing and coding information.
Zoladex patient assistance information can be found through TerSera Therapeutics at the URL: https://www.zoladex.com/
ZOLADEX prescribing information can be found at the link below:
Information regarding ZOLADEX’s side effects can be found at MedlinePlus